Example: Heart Attack

Search clinical trials for: Expanded Access Program (EAP)

Total 10000 results

NCT02755987

No longer available

Expanded Access to ANG1005 for Individual Patients

Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Leptomeningeal Carcinomatosis | Breast Cancer With Recurrent Brain Metastases
NCT06751524

Available

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Melanoma | Sarcoma | Pancreatic Cancer | Ovarian Cancer | Hepatocellular Carcinoma (HCC) | Prostate Cancer | Non-Small Cell Lung Cancer (NSCLC) | Colorectal Cancer (CRC)
NCT05760586

Approved for marketing

Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma

Low-grade Glioma
NCT04530994

Approved for marketing

A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)

Alagille Syndrome
NCT06707480

No longer available

Expanded Access Program for Patients at Risk for Catheter-related Infections Who Are Not Eligible for DefenCath® Clinical Trials

Catheter-related Bloodstream Infection

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register